Home Cart 0 Sign in  
X

[ CAS No. 1006686-08-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1006686-08-3
Chemical Structure| 1006686-08-3
Chemical Structure| 1006686-08-3
Structure of 1006686-08-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1006686-08-3 ]

Related Doc. of [ 1006686-08-3 ]

Alternatived Products of [ 1006686-08-3 ]

Product Details of [ 1006686-08-3 ]

CAS No. :1006686-08-3 MDL No. :MFCD22989187
Formula : C12H18O5 Boiling Point : -
Linear Structure Formula :- InChI Key :MKIVRVCORBPIQI-UHFFFAOYSA-N
M.W : 242.27 Pubchem ID :59030594
Synonyms :

Calculated chemistry of [ 1006686-08-3 ]

Physicochemical Properties

Num. heavy atoms : 17
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.83
Num. rotatable bonds : 4
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 59.0
TPSA : 61.83 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.33 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.18
Log Po/w (XLOGP3) : 0.63
Log Po/w (WLOGP) : 1.05
Log Po/w (MLOGP) : 0.5
Log Po/w (SILICOS-IT) : 2.13
Consensus Log Po/w : 1.3

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.47
Solubility : 8.12 mg/ml ; 0.0335 mol/l
Class : Very soluble
Log S (Ali) : -1.5
Solubility : 7.6 mg/ml ; 0.0314 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.99
Solubility : 2.46 mg/ml ; 0.0102 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.12

Safety of [ 1006686-08-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1006686-08-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1006686-08-3 ]
  • Downstream synthetic route of [ 1006686-08-3 ]

[ 1006686-08-3 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 1489-97-0 ]
  • [ 109-94-4 ]
  • [ 1006686-08-3 ]
YieldReaction ConditionsOperation in experiment
55%
Stage #1: With lithium diisopropyl amide In tetrahydrofuran at -78 - 0℃; for 2 h; Inert atmosphere
Stage #2: at -78℃; for 1.75 h; Inert atmosphere
Step 2: Preparation of ethyl 8-formyl-l,4-dioxaspiro[4.5]decane-8-carboxylate. To a -78 °C solution of ethyl l,4-dioxaspiro[4.5]decane-8-carboxylate (32.31 g, 151 mmol) in THF (250 mL) was added a solution of 2M lithium diisopropylamide (98 mL, 196 mmol) in THF via a cannula over 5 mins. The resulting brown solution was stirred at -78 °C. After lh, the cold bath was replaced with an ice bath and the reaction mixture was stirred at 0 °C for lh. The reaction mixture was again chilled to -78 °C and treated with a solution of ethyl formate (18.65 mL, 226 mmol) in THF (40 mL) added dropwise over 45 min. The resulting light brown reaction mixture was stirred at -78 °C for lh. The cold bath was removed and to the mixture was added dropwise saturated aqueous NH4C1 (250 mL) and the mixture stirred at ambient temperature for 30 min. The resulting yellow mixture was extracted with EtO Ac (3 x 300 mL). The combined organic phase was washed with 0.5N HC1 (300 mL), then with brine, dried over MgS04, filtered and concentrated to a brown viscous oil. The crude material was purified by flash column chromatography over silica gel (750 g silica, step elution 9: 1 hexanes/EtOAc and 5: 1 hexanes/EtOAc) to provide recovered starting material, ethyl l,4-dioxaspiro[4.5]decane- 8-carboxylate (8.6 g, 40.1 mmol, 26.6 percent yield) and the desired product, ethyl 8-formyl- l,4-dioxaspiro[4.5]decane-8-carboxylate (20.1 g, 83 mmol, 55.0 percent yield), both as viscous yellow oils. NMR (400MHz, CHLOROFORM-d) δ 9.50 (s, 1H), 4.17 (q, J=7.2 Hz, 2H), 3.94 - 3.86 (m, 4H), 2.24 - 2.09 (m, 2H), 2.01 (ddd, J=13.5, 8.3, 5.1 Hz, 2H), 1.75 - 1.48 (m, 4H), 1.23 (t, J=7.2 Hz, 3H).
55%
Stage #1: With lithium diisopropyl amide In tetrahydrofuran at -78 - 0℃; for 2 h;
Stage #2: at -78℃; for 1.45 h;
To a -78 °C solution of ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate (32.31 g, 151 mmol) in THF (250 mL) was added a solution of 2M lithium diisopropylamide (98 mL, 196 mmol) in THF via a cannula over 5 mins. The resulting brown solution was stirred at -78 °C. After 1h, the cold bath was replaced with an ice bath and the reaction mixture was stirred at 0 °C for 1h. The reaction mixture was again chilled to -78 °C and treated with a solution of ethyl formate (18.65 mL, 226 mmol) in THF (40mL) added dropwise over 45 min. The resulting light brown reaction mixture was stirred at -78 °C for 1h. The cold bath was removed and to the mixture was added dropwise saturated aqueous NH4Cl (250mL) and the mixture stirred at ambient temperature for 30 min. The resulting yellow mixture was extracted with EtOAc (3 x 300 mL). The combined organic phase was washed with 0.5N HCl (300mL), then with brine, dried over MgSO4, filtered and concentrated to a brown viscous oil. The crude material was purified by flash column chromatography over silica gel (750 g silica, step elution 9:1 hexanes/EtOAc and 5:1 hexanes/EtOAc) to provide recovered starting material, ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate (8.6 g, 40.1 mmol, 26.6percent yield) and the desired product, ethyl 8-formyl-1,4-dioxaspiro[4.5]decane-8-carboxylate (20.1 g, 83 mmol, 55.0 percent yield), both as viscous yellow oils. H1 NMR (400 MHz, CHLOROFORM-d) δ 9.50(s, 1H), 4.17(q, J=7.2 Hz, 2H), 3.94-3.86(m, 4H), 2.24-2.09(m, 2H), 2.01(ddd, J=13.5, 8.3, 5.1 Hz, 2H), 1.75-1.48(m, 4H), 1.23(t, J=7.2 Hz, 3H).
39%
Stage #1: With lithium diisopropyl amide In tetrahydrofuran at -78℃; for 2.5 h; Cooling with ice
Stage #2: at -78℃; for 2 h; Molecular sieve
To a solution of ethyl 1,4-dioxaspiro[4.5jdecane-8-carboxylate (21 g, 98 mmol) in THF(150 mL) at -78 °C was added 2M LDA (64 mL, 127 mmol) dropwise. The resultingsolution was stirred at -78 °C for 1 h, then in an ice bath for 1.5 h. The reaction mixturewas chilled back to -78 °C and molecular sieves were added. Dried ethyl formate (12 mL,147 mmol) was added dropwise slowly over 1 h. The reaction mixture was stirred at -78°C for 1 h. The cold bath was removed and the reaction was quenched with a saturatedsolution of NH4C1 in 0.5 N HC1 (250 mL) dropwise. The mixture was extracted with EtOAc (3 x 200 mL). The combined organic layer was washed with saturated solution of NH4C1 in 0.5 N HC1 (200 mL), brine (200 mL), dried over Na2SO4, and concentrated in vacuo. The cmde product was purified by silica gel column eluted with 0-20 percent ethyl acetate I hexanes to give the desired product as an oil (9.3 g, 39 percent). ‘H NMR (400MHz,CHLOROFORM-d) ö 9.54 (s, 1H), 4.21 (q, J=7.1 Hz, 2H), 3.98 - 3.90 (m, 4H), 2.25 -2.16 (m, 2H), 2.10 - 2.01 (m, 2H), 1.74 - 1.60 (m, 4H), 1.27 (t, J=7.2 Hz, 3H).
Reference: [1] Patent: WO2015/157483, 2015, A1, . Location in patent: Page/Page column 73-75
[2] Patent: WO2016/77561, 2016, A1, . Location in patent: Page/Page column 85
[3] Patent: WO2017/134596, 2017, A1, . Location in patent: Page/Page column 64; 65
  • 2
  • [ 78461-64-0 ]
  • [ 1006686-08-3 ]
Reference: [1] Patent: US2007/299080, 2007, A1, . Location in patent: Page/Page column 61-62
  • 3
  • [ 17159-79-4 ]
  • [ 1006686-08-3 ]
Reference: [1] Patent: WO2015/157483, 2015, A1,
[2] Patent: WO2016/77561, 2016, A1,
[3] Patent: WO2017/134596, 2017, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1006686-08-3 ]

Aldehydes

Chemical Structure| 124752-23-4

[ 124752-23-4 ]

tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate

Similarity: 0.71

Chemical Structure| 78008-36-3

[ 78008-36-3 ]

(R)-1,4-Dioxaspiro[4.5]decane-2-carbaldehyde

Similarity: 0.66

Chemical Structure| 94994-25-9

[ 94994-25-9 ]

Methyl 4-formylbicyclo[2.2.2]octane-1-carboxylate

Similarity: 0.63

Chemical Structure| 20417-61-2

[ 20417-61-2 ]

Ethyl 2-formylcyclopropanecarboxylate

Similarity: 0.61

Chemical Structure| 54274-80-5

[ 54274-80-5 ]

trans-Methyl 4-formylcyclohexanecarboxylate

Similarity: 0.60

Esters

Chemical Structure| 24730-88-9

[ 24730-88-9 ]

Ethyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.95

Chemical Structure| 1489-97-0

[ 1489-97-0 ]

Ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.93

Chemical Structure| 87787-08-4

[ 87787-08-4 ]

Methyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.93

Chemical Structure| 26845-47-6

[ 26845-47-6 ]

Methyl 1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.91

Chemical Structure| 189509-22-6

[ 189509-22-6 ]

Ethyl 2-(8-hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)acetate

Similarity: 0.87

Related Parent Nucleus of
[ 1006686-08-3 ]

Aliphatic Heterocycles

Chemical Structure| 24730-88-9

[ 24730-88-9 ]

Ethyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.95

Chemical Structure| 1489-97-0

[ 1489-97-0 ]

Ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.93

Chemical Structure| 87787-08-4

[ 87787-08-4 ]

Methyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.93

Chemical Structure| 26845-47-6

[ 26845-47-6 ]

Methyl 1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.91

Chemical Structure| 189509-22-6

[ 189509-22-6 ]

Ethyl 2-(8-hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)acetate

Similarity: 0.87

Spiroes

Chemical Structure| 24730-88-9

[ 24730-88-9 ]

Ethyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.95

Chemical Structure| 1489-97-0

[ 1489-97-0 ]

Ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.93

Chemical Structure| 87787-08-4

[ 87787-08-4 ]

Methyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.93

Chemical Structure| 26845-47-6

[ 26845-47-6 ]

Methyl 1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.91

Chemical Structure| 189509-22-6

[ 189509-22-6 ]

Ethyl 2-(8-hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)acetate

Similarity: 0.87

Dioxolanes

Chemical Structure| 24730-88-9

[ 24730-88-9 ]

Ethyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.95

Chemical Structure| 1489-97-0

[ 1489-97-0 ]

Ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.93

Chemical Structure| 87787-08-4

[ 87787-08-4 ]

Methyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.93

Chemical Structure| 26845-47-6

[ 26845-47-6 ]

Methyl 1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.91

Chemical Structure| 189509-22-6

[ 189509-22-6 ]

Ethyl 2-(8-hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)acetate

Similarity: 0.87